💊 Bangladesh gets an insulin deal; Flu gets a needle-free vaccine; Gavi gets a new CEO; Will you be our Valentine?

#276 | More money, more dum-dums; mRNA for Shingles comes; Epigenetics can do them sums

Hello, and welcome back to The Kable, a fairly light one today.

Vaxxas, which most recently won a grant from CEPI for its needle-free vaccine tech, has begun Phase 1 trials of its influenza vaccine in Australia.

India's Biocon, which received a CRL from the US FDA for its Avastin insulin biosimilar last month, now sees its application rejected by the agen…